Department of Urology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
J Coll Physicians Surg Pak. 2024 Jun;34(6):702-706. doi: 10.29271/jcpsp.2024.06.702.
To investigate the potential clinical benefits of mid-urethral sling (MUS) and urethral dilatation (UD) operations for the treatment of stress urinary incontinence (SUI) combined with urethral stricture.
Descriptive study. Place and Duration of the Study: Department of Urology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China, from January 2017 to 2022.
Patients with Qmax <15ml/s or PVR >50ml, and video urodynamic study (VUDS) capable of confirming the presence and position of urethral stricture were included. The clinical efficacy was evaluated by International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) questionnaire, maximum flow rate (Qmax), and postvoid residual (PVR) urine. ICIQ-SF, Qmax, and PVR were measured presurgery, on postoperative 2-week, and 1-month postsurgery.
There were total 19 patients with an average age of 61.37 ± 11.28 years (range 39-84) with SUI and urethral stricture. ICIQ-SF scores were decreased significantly at one month postoperatively compared with the preoperative [5.0 (0.0, 7.0) vs. 14.0 (13.0, 15.0), p <0.001]. Qmax was increased dramatically compared with the preoperative [21.3 (14.0, 28.4) vs. 13.0 (8.7,18.0), p <0.001], and PVR was decreased remarkably than the preoperative [0.0 (0.0,0.0) vs. 0.0 (0.0,60.0), p = 0.018]. Of 19 patients primarily managed with MUS and UD, two patients experienced recurrence requiring repetitive dilation till sling excision surgery was conducted, and improvement was evident in one patient after repeating UD.
The overall incidence of SUI combined with urethral stricture in women is low. With a success rate of 89.5%, MUS and UD were effective therapies for the co-existence of SUI with urethral stricture, and repeated UD can be performed safely if necessary in long-term follow-up.
Stress urinary incontinence, Urethral stricture, Mid-urethral sling, Urethral dilatation.
探讨治疗压力性尿失禁(SUI)合并尿道狭窄的中尿道吊带术(MUS)和尿道扩张术(UD)的潜在临床获益。
描述性研究。地点和研究时间:首都医科大学附属北京朝阳医院泌尿外科,中国北京,2017 年 1 月至 2022 年。
纳入 Qmax<15ml/s 或 PVR>50ml 且能明确尿道狭窄位置的患者,行视频尿动力学检查(VUDS)。采用国际尿失禁咨询问卷简表(ICIQ-SF)问卷、最大尿流率(Qmax)和剩余尿量(PVR)评估临床疗效。分别于术前、术后 2 周和 1 个月测量 ICIQ-SF、Qmax 和 PVR。
共有 19 例平均年龄 61.37±11.28 岁(39-84 岁)的 SUI 合并尿道狭窄患者。术后 1 个月 ICIQ-SF 评分明显低于术前[5.0(0.0,7.0)比 14.0(13.0,15.0),p<0.001]。Qmax 明显高于术前[21.3(14.0,28.4)比 13.0(8.7,18.0),p<0.001],PVR 明显低于术前[0.0(0.0,0.0)比 0.0(0.0,60.0),p=0.018]。19 例患者主要采用 MUS 和 UD 治疗,2 例复发患者需反复扩张,2 例患者行吊带切除,1 例患者反复 UD 后症状改善。
女性合并 SUI 与尿道狭窄的总体发生率较低。MUS 和 UD 治疗 SUI 合并尿道狭窄的成功率为 89.5%,如果需要,在长期随访中可安全进行重复 UD。
压力性尿失禁,尿道狭窄,中尿道吊带术,尿道扩张术。